fimepinostat: Clinical Trials

3 trials of fimepinostat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1
Phase 11Completed 1
Phase 21Recruiting 1

Follow fimepinostat: new trials by email Literature Review of fimepinostat trials Research Report on fimepinostat

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
Fimepinostat - Cushing Disease
Phase 2RecruitingUniversity of California, Los Angeles202025-01-162026-07-17
Fimepinostat in Treating Brain Tumors in Children and Young Adults
Fimepinostat, Therapeutic Conventional Surgery - Diffuse Intrinsic Pontine Glioma, Recurrent Anaplastic Astrocytoma
Early Phase 1CompletedSabine Mueller, MD, PhD302019-08-072026-11-02
Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma
fimepinostat, Rituximab, venetoclax - Lymphoma, Relapsed Lymphoma
Phase 1CompletedCuris, Inc.1062012-12-012021-05-06

Conditions studied

Astrocytoma (1)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Lymphoma (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Medulloblastoma (1)  ·  Pituitary ACTH Hypersecretion (1)

Sponsors

Curis, Inc. (1)  ·  Sabine Mueller, MD, PhD (1)  ·  University of California, Los Angeles (1)

Countries

United States (3)  ·  Switzerland (1)

Top investigators

Sabine Mueller, MD, PhD (1)

Results publications

PMID 27049457, PMID 28860342